⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL4367126 | 0.97 | — | — | |
| Vinylsulfonic Acid SCHEMBL5130642 | 0.88 | TSHR (0.30) | — | |
| Ethylene Glycol SCHEMBL10584826 | 0.78 | ALDH1A1 (0.31) | — | |
| Ethylene Glycol SCHEMBL413417 | 0.78 | ALDH1A1 (0.31) | — | |
| SCHEMBL413416 | 0.78 | — | — | |
| SCHEMBL3719747 | 0.76 | ALDH1A1 (0.34) | — | |
| SCHEMBL3748421 | 0.73 | — | — | |
| SCHEMBL610721 | 0.73 | — | — | |
| SCHEMBL30709586 | 0.71 | ACHE (0.32) | — | |
| Ethylene SCHEMBL15005585 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050059068-A1 | Compositions and methods using dendrimer-treated microassays | STRATAGENE CALIFORNIA | 2005-03-17 | — | — | US | claimed |
| WO-1995021380-A1 | ASSAY FOR SCREENING OF RECEPTOR ANTAGONISTS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1995-08-10 | — | — | WO | claimed |
| US-20160334404-A1 | VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFE | DIAZYME LABORATORIES, INC. | 2016-11-17 | — | — | US | disclosed |
| EP-3049813-A2 | LONG SHELF-LIFE KITS AND METHODS FOR STANDARDIZING, VERIFYING, CALIBRATING OR RECALIBRATING DETECTION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | Diadexus, Inc. (US) | 2016-08-03 | — | — | EP | disclosed |
| WO-2015048177-A2 | LONG SHELF-LIFE KITS AND METHODS FOR STANDARDIZING, VERIFYING, CALIBRATING OR RECALIBRATING DETECTION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | DIADEXUS, INC. (US) | 2015-04-02 | — | — | WO | disclosed |
| US-20150086998-A1 | VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFE | DIAZYME LABORATORIES, INC. | 2015-03-26 | — | — | US | disclosed |
| US-20150086999-A1 | LONG SHELF-LIFE KITS AND METHODS FOR STANDARDIZING, VERIFYING, CALIBRATING OR RECALIBRATING DETECTION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | DIAZYME LABORATORIES, INC. | 2015-03-26 | — | — | US | disclosed |
| US-8673552-B2 | Druggable regions in the dengue virus envelope glycoprotein and methods of using the same | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2014-03-18 | — | — | US | disclosed |
| US-20100105151-A1 | Novel Druggable Regions in the Dengue Virus Envelope Glycoprotein and Methods of Using the Same | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2010-04-29 | — | — | US | disclosed |
| EP-1447081-B1 | Sugar-modified liposome and products comprising the liposome | NAT INST OF ADVANCED IND SCIEN (JP) | 2010-02-10 | — | — | EP | disclosed |
| US-7524624-B2 | Druggable regions in the dengue virus envelope glycoprotein and methods of using the same | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2009-04-28 | — | — | US | disclosed |
| US-20060193906-A1 | Sugar-modified liposome and products comprising the liposome | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY | 2006-08-31 | — | — | US | disclosed |
| US-7070801-B2 | Sugar-modified liposome and products comprising the liposome | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2006-07-04 | — | — | US | disclosed |
| EP-1655038-A1 | TARGET-DIRECTED AND ENTERIC ABSORPTION-CONTROLLED LIPOSOME HAVING SUGAR CHAIN AND CANCER REMEDY AND DIAGNOSTIC CONTAINING THE SAME | National Institute of Advanced Industrial Science and Technology (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1655022-A1 | REMEDY OR DIAGNOSTIC FOR INFLAMMATORY DISEASE CONTAINING TARGET-DIRECTING LIPOSOME | National Institute of Advanced Industrial Science and Technology (JP) | 2006-05-10 | — | — | EP | disclosed |
| US-20050059068-A1 | Compositions and methods using dendrimer-treated microassays | STRATAGENE CALIFORNIA | 2005-03-17 | — | — | US | disclosed |
| WO-2005002501-A2 | NOVEL DRUGGABLE REGIONS IN THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN AND METHODS OF USING THE SAME | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2005-01-13 | — | — | WO | disclosed |
| EP-1447081-A1 | Sugar-modified liposome and products comprising the liposome | National Institue of Advanced Industrial Science and Technology (JP) | 2004-08-18 | — | — | EP | disclosed |
| US-20030143267-A1 | Sugar-modified liposome and products comprising the liposome | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL | 2003-07-31 | — | — | US | disclosed |
| WO-1995021380-A1 | ASSAY FOR SCREENING OF RECEPTOR ANTAGONISTS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1995-08-10 | — | — | WO | disclosed |